OR WAIT null SECS
Accelerated Enrollment Solutions and Science 37 are collaborating to recruit and enroll clinical trial participants who live beyond the geographic location of traditional research sites. The collaboration enables AES to provide its customers with increased patient access by reaching beyond its existing, physical site infrastructure of more than 180 research sites. The companies also are working to rapidly deliver continuity solutions for clinical trials affected by the COVID-19 pandemic.
For more information, click here.